Dr Laura Price studied at Bristol University School of Medicine, graduating in 1998, having obtained an intercalated BSc in cellular and molecular pathology in 1995.
Further to her specialist experience in pulmonary hypertension, Dr Price has broad training in general, respiratory and critical care medicine. She also has experience in anaesthesia, obtaining her primary Fellowship of the Royal College of Anaesthetists (FRCA) in earlier training posts.
She achieved membership of the Royal College of Physicians in 2003, and undertook specialist training in respiratory and general medicine on the North West London rotation between 2005 and 2013. During this time, she gained a PhD at the NHLI at Imperial College London in pulmonary hypertension. She spent 12 months in the largest pulmonary hypertension centre in Europe (Paris, France) in 2008, obtaining advanced clinical and research experience in the condition.
Dr Price joined Royal Brompton Hospital in June 2014 as a locum consultant in the National Pulmonary Hypertension Service, and she was appointed as substantive consultant in December 2015.
Areas of expertise
Dr Price is a consultant respiratory physician at Royal Brompton & Harefield NHS Foundation Trust and an honorary clinical senior lecturer at the National Heart and lung Institute (NHLI) at Imperial College, London.
She is an integral member of the National Pulmonary Hypertension Service at Royal Brompton Hospital, consulting with patients who have this condition and other pulmonary vascular diseases.
She also runs outpatient pulmonary hypertension clinics, and supervises care of inpatients with the condition with emergencies relating to pulmonary hypertension or co-existing medical conditions. With haematology colleagues, Dr Price is setting up a new service following-up patients after pulmonary emboli at Royal Brompton Hospital.
Dr Price’s particular current areas of research interest include:
- pulmonary hypertension in lung diseases, notably interstitial lung disease
- chronic obstructive pulmonary disease (COPD)
- sleep disorders.
Among several ongoing clinical projects, she is co-applicant on a National Institute for Health Research (NIHR) application to study the benefits of sildenafil in patients with COPD, and is co-supervising an MD-Res student examining the power of serial change in non-invasive surrogates of pulmonary hypertension in patients with interstitial lung disease.
During her PhD studentship, Dr Price demonstrated that activation of the key inflammatory signalling molecule, NF-kappa B, was enhanced in lungs from patients with idiopathic pulmonary arterial hypertension.
Further work using corticosteroids in a disease model and in relevant lung cells showed that suppression of inflammation in pulmonary arterial hypertension might be a potential therapeutic target. Her PhD led to four well-cited peer-reviewed publications.
Teaching and publications
Dr Price has over 15 years’ experience in undergraduate and postgraduate teaching. She has over 30 peer-reviewed articles across a wide range of topics in respiratory disease (notably related to pulmonary hypertension and critical care), as well as authoring many book chapters.
Private patient referral
If you would like to make an appointment with this specialist for private care, contact the RB&HH Specialist care team.